All-Atom
Contacts
Clashscore, all atoms:1.76 100th percentile* (N=456, 2.20Å ± 0.25Å)
Clashscore is the number of serious steric overlaps (> 0.4 Å) per 1000 atoms.
Protein
Geometry
Poor rotamers82.59% Goal: <1%
Ramachandran outliers20.58% Goal: <0.05%
Ramachandran favored32895.91% Goal: >98%
MolProbity score^1.5398th percentile* (N=10167, 2.20Å ± 0.25Å)
Cβ deviations >0.25Å00.00% Goal: 0
Bad backbone bonds:0 / 13890.00% Goal: 0%
Bad backbone angles:0 / 17310.00% Goal: <0.1%
In the two column results, the left column gives the raw count, right column gives the percentage.
* 100th percentile is the best among structures of comparable resolution; 0th percentile is the worst. For clashscore the comparative set of structures was selected in 2004, for MolProbity score in 2006.
^ MolProbity score combines the clashscore, rotamer, and Ramachandran evaluations into a single score, normalized to be on the same scale as X-ray resolution.

Live sorting requires JavaScript enabled and Safari 2, Firefox 1.5, or IE 6

#ResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengths.Bond angles.
Avg: 58.75Clashscore: 1.76Outliers: 2 of 342Poor rotamers: 8 of 309Outliers: 0 of 334Outliers: 0 of 348Outliers: 0 of 348
A 45 ASP86.41--0.2%
chi angles: 227.8,76.8
0.078Å--
A 46 ASN99.02-Favored (50.04%)
General case / -60.6,-18.0
46.2% (t30)
chi angles: 181.7,42
0.034Å--
A 47 GLN63.73-Favored (61.59%)
General case / -72.4,-19.6
26.3% (mt-30)
chi angles: 291.1,172.1,135.2
0.025Å--
A 48 PHE45.08-Favored (19.34%)
General case / -111.0,158.0
79.3% (m-85)
chi angles: 301.9,86.8
0.024Å--
A 49 TYR46.48-Favored (36.75%)
General case / -143.2,148.6
11.5% (p90)
chi angles: 81.6,99.3
0.097Å--
A 50 SER53.8-Favored (39.56%)
General case / -101.6,137.7
57.8% (m)
chi angles: 291.4
0.068Å--
A 51 VAL60.18-Favored (50.94%)
Isoleucine or valine / -128.3,139.8
0%
chi angles: 260.4
0.186Å--
A 52 GLU109.8-Favored (21.02%)
General case / -81.4,116.0
14.8% (tp10)
chi angles: 202.1,58.8,49.9
0.04Å--
A 53 VAL70.820.645Å
HG13 with A 69 PRO HG3
Allowed (1.42%)
Isoleucine or valine / -122.1,89.4
70.5% (t)
chi angles: 171.8
0.154Å--
A 54 GLY73.36-Favored (3.64%)
Glycine / 66.6,-110.7
----
A 55 ASP96.29-Favored (19.41%)
General case / -98.1,-16.7
9% (p-10)
chi angles: 60.9,107.7
0.033Å--
A 56 SER81.66-Favored (17.68%)
General case / -95.6,153.5
9.3% (t)
chi angles: 192.9
0.018Å--
A 57 THR58.28-Favored (49.7%)
General case / -108.1,124.1
44.7% (m)
chi angles: 305.3
0.081Å--
A 58 PHE45.84-Favored (25.03%)
General case / -98.4,113.2
3% (m-85)
chi angles: 262.9,62.7
0.019Å--
A 59 THR41.67-Favored (7.83%)
General case / -105.3,98.1
44.9% (m)
chi angles: 305.3
0.124Å--
A 60 VAL41.4-Favored (14.5%)
Isoleucine or valine / -117.9,164.1
22.8% (m)
chi angles: 302.7
0.105Å--
A 61 LEU40.06-Favored (58.83%)
General case / -64.1,140.1
35.3% (mt)
chi angles: 290,159.9
0.067Å--
A 62 LYS54.13-Favored (27.62%)
General case / -58.5,-18.2
83.9% (mttt)
chi angles: 284.3,166.9,168,176.7
0.124Å--
A 63 ARG47.81-Favored (67.58%)
General case / -63.0,-23.8
16.8% (ptm180)
chi angles: 67.2,183.3,287.4,173.9
0.027Å--
A 64 TYR40.29-Favored (28.46%)
General case / -96.6,116.1
49.5% (m-85)
chi angles: 304.3,117.6
0.047Å--
A 65 GLN78.48-Favored (32.62%)
General case / -123.2,157.6
31.1% (mt-30)
chi angles: 289.5,149.4,31.4
0.043Å--
A 66 ASN70.74-Favored (9.74%)
General case / 54.4,54.2
4.7% (t-20)
chi angles: 192.3,218.5
0.103Å--
A 67 LEU45.35-Favored (37.66%)
General case / -63.2,128.8
6.3% (mp)
chi angles: 266.4,73.6
0.115Å--
A 68 LYS109.95-Favored (17.68%)
Pre-proline / -132.5,122.0
74.5% (mttt)
chi angles: 297.2,201.4,170.7,189.6
0.045Å--
A 69 PRO50.910.645Å
HG3 with A 53 VAL HG13
Favored (80.1%)
Trans proline / -59.4,137.8
21.3% (Cg_exo)
chi angles: 344.4,27.3,92.6
0.033Å--
A 70 ILE43.55-Favored (3.67%)
Isoleucine or valine / -128.0,-1.6
42.1% (pt)
chi angles: 57.8,169.2
0.165Å--
A 71 GLY45.53-Favored (9.25%)
Glycine / 150.4,160.3
----
A 72 SER54.31-Favored (36.67%)
General case / -145.0,162.5
78.4% (p)
chi angles: 59.2
0.006Å--
A 73 GLY48.68-Favored (18.98%)
Glycine / -150.8,-171.5
----
A 74 ALA51.93-Favored (72.66%)
General case / -63.1,-31.5
-0.018Å--
A 75 GLN62.55-Favored (30.9%)
General case / -80.9,-36.6
2.7% (tt0)
chi angles: 210.9,213.6,2
0.055Å--
A 76 GLY48.76-Favored (48.28%)
Glycine / 179.2,178.4
----
A 77 ILE55.84-Favored (27.99%)
Isoleucine or valine / -101.3,137.7
14.8% (mm)
chi angles: 316.6,298.8
0.031Å--
A 78 VAL37.94-Favored (60.38%)
Isoleucine or valine / -118.3,134.9
19.3% (t)
chi angles: 189
0.116Å--
A 79 CYS43.16-Favored (41.13%)
General case / -122.4,151.6
59.3% (m)
chi angles: 285.8
0.009Å--
A 80 ALA39.28-Favored (22.46%)
General case / -95.5,148.5
-0.133Å--
A 81 ALA37.62-Favored (38.92%)
General case / -157.4,161.2
-0.057Å--
A 82 TYR52.39-Favored (43.82%)
General case / -99.4,123.6
42.7% (t80)
chi angles: 171.2,63
0.047Å--
A 83 ASP40.55-Favored (15.81%)
General case / -92.6,103.4
58.5% (t0)
chi angles: 177.3,174.9
0.029Å--
A 84 ALA44.82-Favored (68.19%)
General case / -63.4,-25.2
-0.049Å--
A 85 VAL46.86-Favored (38.39%)
Isoleucine or valine / -73.8,-48.7
45.9% (t)
chi angles: 168
0.134Å--
A 86 LEU50.51-Favored (36.32%)
General case / -85.5,-17.4
79.7% (mt)
chi angles: 289.5,175.7
0.085Å--
A 87 ASP63.95-Favored (7.5%)
General case / 59.7,50.2
21.5% (t0)
chi angles: 180.1,44
0.076Å--
A 88 ARG93.68-Favored (32.76%)
General case / -144.3,146.7
0.3%
chi angles: 233.3,180.5,146.8,168.4
0.201Å--
A 89 ASN59.36-Favored (33.39%)
General case / -84.0,137.9
81% (m-20)
chi angles: 294.6,307.6
0.024Å--
A 90 VAL34.19-Favored (35.31%)
Isoleucine or valine / -128.6,162.5
36% (m)
chi angles: 297.5
0.07Å--
A 91 ALA34.89-Favored (55.48%)
General case / -110.4,130.8
-0.09Å--
A 92 ILE38.91-Favored (62.04%)
Isoleucine or valine / -118.0,119.6
52.9% (mt)
chi angles: 307.5,171
0.075Å--
A 93 LYS45.58-Favored (51.22%)
General case / -103.8,127.5
36.5% (ttpt)
chi angles: 177.5,162.2,75,175.9
0.032Å--
A 94 LYS49.92-Favored (46.42%)
General case / -100.5,129.0
78.2% (tttt)
chi angles: 180.9,194,181.1,186.3
0.023Å--
A 95 LEU36.59-Favored (21.98%)
General case / -108.5,110.5
81.3% (mt)
chi angles: 302,180.5
0.045Å--
A 96 SER53.63-Favored (25.64%)
General case / -89.8,114.0
10.9% (m)
chi angles: 311.2
0.037Å--
A 97 ARG52.75-Favored (12.1%)
Pre-proline / 45.7,61.7
73.1% (mtp85)
chi angles: 300.7,185.6,66.7,83.3
0.064Å--
A 98 PRO40.07-Favored (62.11%)
Trans proline / -59.8,-21.1
38.3% (Cg_endo)
chi angles: 23.5,323.3,154.9
0.054Å--
A 99 PHE42.8-Favored (35.53%)
General case / -80.2,-0.3
21.1% (p90)
chi angles: 49.5,80.2
0.019Å--
A 100 GLN53.03-Favored (62.36%)
General case / -54.8,-34.2
9% (pt20)
chi angles: 68.8,186.3,264.6
0.136Å--
A 101 ASN53.68-Favored (36.76%)
General case / -149.6,163.8
21.1% (p30)
chi angles: 64.2,64.1
0.131Å--
A 102 GLN88.92-Favored (68.97%)
General case / -53.8,-43.1
2.9% (tp-100)
chi angles: 209.6,80.6,211.3
0.009Å--
A 103 THR58.93-Favored (48%)
General case / -63.7,-53.6
18.5% (m)
chi angles: 310.9
0.132Å--
A 104 HIS54.82-Favored (95.77%)
General case / -64.9,-40.9
51.5% (m-70)
chi angles: 285.3,309.5
0.032Å--
A 105 ALA42.67-Favored (63.76%)
General case / -65.4,-50.9
-0.057Å--
A 106 LYS103.66-Favored (77.65%)
General case / -57.3,-48.9
20.3% (tptm)
chi angles: 186.5,82.7,178.3,285.6
0.023Å--
A 107 ARG66.93-Favored (70.92%)
General case / -59.9,-51.1
60.5% (ttt180)
chi angles: 188.9,181.6,162.6,173.9
0.106Å--
A 108 ALA40.7-Favored (96.63%)
General case / -60.9,-41.7
-0.038Å--
A 109 TYR66.53-Favored (40.39%)
General case / -67.7,-52.2
91.6% (t80)
chi angles: 179.5,78.1
0.09Å--
A 110 ARG84.10.536Å
CZ with A 211 ALA HB2
Favored (82.79%)
General case / -57.8,-41.7
38.1% (ttt-85)
chi angles: 190.7,173.5,159.1,257.8
0.072Å--
A 111 GLU67.54-Favored (67.87%)
General case / -61.5,-51.6
84.6% (mt-10)
chi angles: 280.8,178.1,163.6
0.032Å--
A 112 LEU53.06-Favored (67.53%)
General case / -53.7,-49.6
18.6% (mt)
chi angles: 275.8,167.8
0.024Å--
A 113 VAL54.98-Favored (63.22%)
Isoleucine or valine / -64.9,-51.7
46% (t)
chi angles: 168
0.113Å--
A 114 LEU56.36-Favored (81.81%)
General case / -64.0,-35.8
66.5% (mt)
chi angles: 292.3,182.2
0.142Å--
A 115 MET63.58-Favored (4.25%)
General case / -58.7,-12.5
42.1% (mtm)
chi angles: 278.6,178.1,303.1
0.11Å--
A 116 LYS108.83-Favored (13.04%)
General case / -104.7,-23.6
93.1% (mttt)
chi angles: 295.3,167.9,181.9,180.7
0.027Å--
A 117 CYS74.36-Favored (28.22%)
General case / -89.4,8.9
92.8% (m)
chi angles: 293.6
0.068Å--
A 118 VAL64.10.434Å
HA with A 373 PRO HG2
Favored (33.62%)
Isoleucine or valine / -131.7,146.3
30% (m)
chi angles: 294.9
0.182Å--
A 119 ASN76.79-Allowed (1.57%)
General case / -147.2,84.0
42.7% (t30)
chi angles: 180.6,41.5
0.076Å--
A 120 HIS50.2-Favored (16.99%)
General case / -153.1,137.8
52.6% (t-80)
chi angles: 196.8,278.2
0.035Å--
A 121 LYS81.59-Favored (63.68%)
General case / -67.2,-15.4
55.7% (pttt)
chi angles: 62.4,177.8,170.9,188.8
0.121Å--
A 122 ASN40.62-Favored (49.55%)
General case / -97.9,5.0
28.9% (m120)
chi angles: 301.2,127.8
0.143Å--
A 123 ILE39.04-Favored (47.03%)
Isoleucine or valine / -122.1,140.1
47.6% (mm)
chi angles: 303.9,298.4
0.04Å--
A 124 ILE51.09-Allowed (1.23%)
Isoleucine or valine / -45.0,137.8
7.4% (tt)
chi angles: 181.5,183.4
0.064Å--
A 125 SER59.42-Favored (42.22%)
General case / -131.8,130.8
32.9% (t)
chi angles: 183.9
0.091Å--
A 126 LEU42.91-Favored (33.99%)
General case / -84.0,136.6
17% (mt)
chi angles: 287.3,191.8
0.055Å--
A 127 LEU40.58-Favored (15.41%)
General case / -88.8,-37.4
0%
chi angles: 255.1,19.8
0.108Å--
A 128 ASN45.18-Favored (33.89%)
General case / -159.4,159.5
9.5% (t-20)
chi angles: 212.1,354.1
0.046Å--
A 129 VAL41.45-Favored (7.33%)
Isoleucine or valine / -146.8,129.0
2.3% (p)
chi angles: 47.1
0.143Å--
A 130 PHE37.68-Favored (40.56%)
General case / -153.3,163.1
53.7% (p90)
chi angles: 64.1,90.1
0.041Å--
A 131 THR40.93-Favored (22.35%)
Pre-proline / -132.6,131.7
5.8% (t)
chi angles: 177.1
0.13Å--
A 132 PRO47.09-Favored (36.59%)
Trans proline / -69.0,-21.9
3.2% (Cg_exo)
chi angles: 354.9,21.1,91.9
0.053Å--
A 133 GLN51.1-Favored (39.05%)
General case / -77.0,132.5
13.7% (mp0)
chi angles: 295.8,94.6,37.9
0.118Å--
A 134 LYS109.91-Favored (34.41%)
General case / -81.3,-28.6
86.7% (mttt)
chi angles: 298.8,169.7,192.3,176.5
0.03Å--
A 135 THR62.2-Favored (34.74%)
General case / -129.3,159.9
51.8% (p)
chi angles: 55.8
0.056Å--
A 136 LEU63.5-Favored (80.21%)
General case / -58.9,-39.0
43.3% (tp)
chi angles: 170.2,63.8
0.026Å--
A 137 GLU99.77-Favored (94.93%)
General case / -64.5,-40.1
1.7% (tp10)
chi angles: 227.2,49.6,53.4
0.092Å--
A 138 GLU82.37-Favored (40.73%)
General case / -82.7,-18.5
48.9% (mt-10)
chi angles: 292.4,175.6,100.7
0.035Å--
A 139 PHE46.91-Favored (5.68%)
General case / -48.1,123.0
42% (t80)
chi angles: 176.5,58.5
0.102Å--
A 140 GLN77.34-Allowed (0.99%)
General case / -131.9,-54.7
31.2% (mt-30)
chi angles: 289.8,206.1,71.9
0.018Å--
A 141 ASP44.86-Favored (37.51%)
General case / -114.8,149.1
15.2% (m-20)
chi angles: 313.1,125
0.024Å--
A 142 VAL35.74-Favored (72.5%)
Isoleucine or valine / -120.4,131.5
93.5% (t)
chi angles: 175.7
0.014Å--
A 143 TYR38.37-Favored (56.47%)
General case / -114.6,128.7
81.4% (m-85)
chi angles: 293.6,81.6
0.005Å--
A 144 LEU38.33-Favored (51.76%)
General case / -114.8,137.6
65.2% (mt)
chi angles: 304.1,173.8
0.027Å--
A 145 VAL33.38-Favored (67.41%)
Isoleucine or valine / -122.7,133.9
28.1% (t)
chi angles: 186.4
0.083Å--
A 146 MET34.55-Favored (14.56%)
General case / -142.4,171.1
24.9% (ptm)
chi angles: 74.5,173.9,280.6
0.02Å--
A 147 GLU64.19-Favored (57.05%)
General case / -58.2,135.1
16% (tt0)
chi angles: 200.2,200.2,140.3
0.164Å--
A 148 LEU36.15-Favored (22.35%)
General case / -73.2,122.7
43.3% (tp)
chi angles: 178.9,69.7
0.054Å--
A 149 MET40.5-Favored (14.26%)
General case / -95.3,161.0
78.5% (mmm)
chi angles: 306.1,292.6,278.2
0.107Å--
A 150 ASP46.61-Favored (21.93%)
General case / -85.4,-33.5
73.5% (m-20)
chi angles: 296.5,135.6
0.06Å--
A 151 ALA36.77-Favored (35.72%)
General case / -156.9,165.6
-0.073Å--
A 152 ASN50.21-Favored (6.93%)
General case / -98.1,173.7
48.2% (p30)
chi angles: 61.2,21.5
0.098Å--
A 153 LEU38.69-Favored (60.33%)
General case / -74.3,-19.8
13.3% (tp)
chi angles: 202.4,57.4
0.1Å--
A 154 CYS43.15-Favored (85.05%)
General case / -60.6,-47.7
98.7% (m)
chi angles: 294.6
0.014Å--
A 155 GLN63.01-Favored (99.36%)
General case / -62.2,-43.2
77.8% (mt-30)
chi angles: 293.6,172.4,289.6
0.037Å--
A 156 VAL43.50.415Å
O with A 159 MET HG2
Favored (82.59%)
Isoleucine or valine / -62.4,-39.0
54.7% (t)
chi angles: 169.3
0.126Å--
A 157 ILE42.13-Favored (62.77%)
Isoleucine or valine / -59.9,-35.8
6.2% (mt)
chi angles: 273.1,160.8
0.096Å--
A 158 GLN82.62-Favored (52.7%)
General case / -72.1,-8.1
66.3% (mt-30)
chi angles: 288.9,179.9,277.9
0.018Å--
A 159 MET54.930.415Å
HG2 with A 156 VAL O
Favored (18.91%)
General case / -112.7,159.4
19.8% (ptp)
chi angles: 63.9,194,70.7
0.139Å--
A 160 GLU58.16-Favored (31.87%)
General case / -81.7,126.5
46.1% (mt-10)
chi angles: 272.4,184.5,8.4
0.1Å--
A 161 LEU48.62-Favored (33.55%)
General case / -113.2,149.6
14.3% (mt)
chi angles: 299.9,156
0.064Å--
A 162 ASP65.08-Favored (12.71%)
General case / -80.7,173.3
10.8% (p-10)
chi angles: 59.5,115.6
0.051Å--
A 163 HIS44.97-Favored (69.88%)
General case / -69.5,-31.5
96.6% (m-70)
chi angles: 292.9,284.8
0.096Å--
A 164 GLU86.52-Favored (71.86%)
General case / -63.1,-50.1
15.8% (tt0)
chi angles: 177.9,201.6,90
0.036Å--
A 165 ARG93.22-Favored (64.13%)
General case / -69.1,-47.9
82.2% (mtt85)
chi angles: 286.6,180.5,182.5,88.7
0.089Å--
A 166 MET53.37-Favored (81.5%)
General case / -59.6,-48.5
47.7% (ttm)
chi angles: 195.5,184.1,288.8
0.116Å--
A 167 SER36.61-Favored (90.22%)
General case / -65.2,-38.4
84.7% (p)
chi angles: 68.4
0.089Å--
A 168 TYR43.95-Favored (96.02%)
General case / -64.5,-42.1
26.1% (t80)
chi angles: 184.1,51.1
0.064Å--
A 169 LEU35.77-Favored (99.38%)
General case / -62.0,-43.2
88.5% (mt)
chi angles: 293.2,169.3
0.041Å--
A 170 LEU35.3-Favored (90.79%)
General case / -65.7,-42.8
47.8% (mt)
chi angles: 292.3,162.3
0.071Å--
A 171 TYR48.97-Favored (81.54%)
General case / -56.6,-45.2
41.5% (t80)
chi angles: 165.3,72.3
0.026Å--
A 172 GLN43.96-Favored (88.3%)
General case / -66.7,-40.0
44.3% (mt-30)
chi angles: 289.3,176.7,94.6
0.054Å--
A 173 MET41.79-Favored (95.1%)
General case / -61.4,-45.2
15.4% (mtt)
chi angles: 291.6,174.5,233.3
0.041Å--
A 174 LEU37.42-Favored (85.87%)
General case / -63.5,-37.1
26.4% (mt)
chi angles: 295.2,159
0.121Å--
A 175 CYS43.02-Favored (72.35%)
General case / -63.3,-49.8
60.5% (m)
chi angles: 286
0.011Å--
A 176 GLY38.79-Favored (58.16%)
Glycine / -55.0,-50.6
----
A 177 ILE41.97-Favored (91.53%)
Isoleucine or valine / -61.0,-47.9
22% (mt)
chi angles: 292.8,150.4
0.1Å--
A 178 LYS73.32-Favored (73.26%)
General case / -54.9,-43.5
27.4% (tptt)
chi angles: 166.2,87.4,165.5,159.9
0.032Å--
A 179 HIS50.41-Favored (97.69%)
General case / -61.0,-44.2
59.7% (t60)
chi angles: 194.1,71.3
0.055Å--
A 180 LEU46.04-Favored (92.28%)
General case / -61.5,-45.9
77.7% (mt)
chi angles: 294.7,181.4
0.069Å--
A 181 HIS48.1-Favored (84.63%)
General case / -60.1,-39.0
57.4% (m170)
chi angles: 290.6,175
0.036Å--
A 182 SER58.02-Favored (68.26%)
General case / -65.2,-26.6
55.3% (p)
chi angles: 73.4
0.082Å--
A 183 ALA53.4-Favored (43.8%)
General case / -96.7,8.6
-0.02Å--
A 184 GLY47.42-Favored (84.77%)
Glycine / 80.9,10.7
----
A 185 ILE51.42-Favored (30.84%)
Isoleucine or valine / -94.2,114.4
12.9% (mt)
chi angles: 303.7,148.5
0.103Å--
A 186 ILE45.8-Favored (28.44%)
Isoleucine or valine / -110.7,109.4
53.1% (mt)
chi angles: 300.4,160.2
0.162Å--
A 187 HIS36.95-Allowed (0.3%)
General case / -54.9,-67.1
39.6% (t-80)
chi angles: 202.6,289.3
0.104Å--
A 188 ARG72.030.401Å
HG2 with A 244 VAL HG11
Allowed (1.94%)
General case / 74.0,-6.0
61.4% (mtm180)
chi angles: 290.4,194.1,290,156.2
0.137Å--
A 189 ASP50.13-Favored (2.17%)
General case / -138.9,36.3
33.3% (t0)
chi angles: 198.5,19.5
0.106Å--
A 190 LEU40.94-Favored (55.03%)
General case / -63.6,134.2
20.3% (mt)
chi angles: 280.8,159.5
0.112Å--
A 191 LYS69.23-Favored (35.28%)
Pre-proline / -148.8,151.4
9.2% (ptpt)
chi angles: 65.8,192,94.2,183.9
0.091Å--
A 192 PRO33.4-Favored (68.23%)
Trans proline / -63.8,-26.3
18.4% (Cg_endo)
chi angles: 18.1,333.4,144.3
0.094Å--
A 193 SER38.71-Favored (65.95%)
General case / -67.0,-20.8
84.6% (p)
chi angles: 61
0.025Å--
A 194 ASN43.9-Favored (18.73%)
General case / -102.3,19.5
68.9% (m-20)
chi angles: 280.1,321.3
0.088Å--
A 195 ILE34.32-Favored (67.62%)
Isoleucine or valine / -127.8,126.9
29.5% (mt)
chi angles: 303.5,156.6
0.056Å--
A 196 VAL34.08-Favored (21.49%)
Isoleucine or valine / -119.1,152.8
4% (m)
chi angles: 283.8
0.151Å--
A 197 VAL39.55-Favored (43.37%)
Isoleucine or valine / -131.9,158.9
13.3% (m)
chi angles: 306.8
0.078Å--
A 198 LYS89.69-Favored (14.7%)
General case / -110.0,162.3
34.7% (mtmt)
chi angles: 272.1,202.6,287.3,186.9
0.052Å--
A 199 SER61.1-Favored (25.77%)
General case / -54.4,-25.6
63.8% (m)
chi angles: 292.3
0.018Å--
A 200 ASP58.7-Favored (14.4%)
General case / -85.9,10.3
42.1% (p-10)
chi angles: 68.9,171.1
0.075Å--
A 201 CYS53.09-Favored (4.75%)
General case / 74.0,8.3
0.5%
chi angles: 218.3
0.115Å--
A 202 THR47.5-Favored (40.72%)
General case / -76.7,141.8
70.7% (p)
chi angles: 63.3
0.164Å--
A 203 LEU35.03-Favored (49.89%)
General case / -126.7,148.4
8.4% (tt)
chi angles: 177,150.3
0.107Å--
A 204 LYS49.78-Favored (38.31%)
General case / -138.2,138.2
62.9% (mttm)
chi angles: 297.4,186.2,192.9,289.9
0.031Å--
A 205 ILE37.05-Favored (42.74%)
Isoleucine or valine / -89.8,125.1
77.2% (mt)
chi angles: 299.9,176.1
0.085Å--
A 206 LEU34.46-Favored (30.65%)
General case / -84.3,-22.4
37.8% (mt)
chi angles: 301.1,165
0.052Å--
A 207 ASP43.98-Favored (8.2%)
General case / -127.6,175.5
5.8% (p-10)
chi angles: 76.4,135.4
0.039Å--
A 208 PHE41-Favored (14.17%)
General case / -116.4,8.6
98.3% (m-85)
chi angles: 297.9,94.3
0.098Å--
A 209 GLY47.03-Favored (30.94%)
Glycine / 80.1,-149.3
----
A 210 LEU59.68-Favored (16.7%)
General case / -84.4,-41.4
81.5% (mt)
chi angles: 300.9,174.1
0.054Å--
A 211 ALA65.150.536Å
HB2 with A 110 ARG CZ
Allowed (0.21%)
General case / 65.8,168.4
-0.066Å--
A 212 ARG140.43---0.039Å--
A 217 SER102.79--75.8% (p)
chi angles: 58.3
0.058Å--
A 218 PHE94.07-Favored (32.33%)
General case / -96.3,139.5
46.7% (t80)
chi angles: 165.9,75.1
0.056Å--
A 219 MET101.79-Favored (43.72%)
General case / -133.2,134.2
18.4% (ttm)
chi angles: 212.9,179.9,278.4
0.031Å--
A 220 MET102.03-Favored (25.76%)
General case / -82.7,4.3
4% (mmt)
chi angles: 268.7,280.7,192.5
0.033Å--
A 221 THR105.01-Favored (62.51%)
Pre-proline / -84.3,157.1
76.4% (p)
chi angles: 60.1
0.077Å--
A 222 PRO101.16-Favored (8.95%)
Trans proline / -82.0,1.8
10.2% (Cg_endo)
chi angles: 11.6,5.1,100.4
0.054Å--
A 223 TYR102.3-Favored (55.48%)
General case / -67.8,137.7
63.5% (m-85)
chi angles: 284.2,87
0.019Å--
A 224 VAL84.59-Favored (64.89%)
Isoleucine or valine / -109.9,129.4
17.4% (t)
chi angles: 189.6
0.122Å--
A 225 VAL72.41-Favored (37.36%)
Isoleucine or valine / -75.8,129.0
47% (t)
chi angles: 183.2
0.133Å--
A 226 THR54.74-Favored (10.27%)
General case / -71.3,115.3
86.3% (m)
chi angles: 301.7
0.105Å--
A 227 ARG101.26-Favored (16.02%)
General case / -109.0,-5.5
71.9% (mtt85)
chi angles: 288.4,177.3,192,92.1
0.043Å--
A 228 TYR61.4-Favored (3.47%)
General case / -47.8,-29.7
6.6% (m-85)
chi angles: 315.5,135.2
0.067Å--
A 229 TYR37.31-Favored (30.06%)
General case / -103.0,-1.0
28.8% (m-85)
chi angles: 311.2,89.3
0.058Å--
A 230 ARG57.93-Favored (43.67%)
General case / -73.7,135.0
87.7% (mtt180)
chi angles: 282.9,173.6,195.7,182.8
0.119Å--
A 231 ALA41.7-Favored (97.63%)
Pre-proline / -66.1,149.6
-0.026Å--
A 232 PRO46.2-Favored (74.69%)
Trans proline / -52.6,-39.6
76.7% (Cg_exo)
chi angles: 333.3,37.6,87.1
0.02Å--
A 233 GLU55.79-Favored (66.97%)
General case / -64.8,-22.3
13.2% (pm0)
chi angles: 59.9,268.8,42.5
0.166Å--
A 234 VAL48.38-Favored (16.91%)
Isoleucine or valine / -84.3,-42.4
83.6% (t)
chi angles: 174.8
0.114Å--
A 235 ILE58.53-Favored (83.86%)
Isoleucine or valine / -61.9,-39.5
47.5% (mt)
chi angles: 295.5,156.5
0.044Å--
A 236 LEU54.94-Favored (45.37%)
General case / -99.0,8.1
42.8% (mt)
chi angles: 306.7,171.5
0.082Å--
A 237 GLY56.35-Favored (93.78%)
Glycine / 57.7,45.1
----
A 238 MET66.020.444Å
HE2 with A 238 MET HB2
Favored (6.18%)
General case / -97.5,175.6
15.3% (ttm)
chi angles: 209.6,177.4,312.1
0.225Å--
A 239 GLY50.77-Favored (54.43%)
Glycine / -74.2,163.0
----
A 240 TYR54.85-Favored (44.33%)
General case / -142.9,154.7
53.9% (p90)
chi angles: 63.4,87.8
0.029Å--
A 241 LYS73.57-Favored (2.42%)
General case / -122.2,-172.2
54.4% (pttt)
chi angles: 59.9,183.2,175.9,168.7
0.124Å--
A 242 GLU71.46-Favored (62.38%)
General case / -51.5,-43.5
40.9% (mp0)
chi angles: 281.6,82.2,171.3
0.059Å--
A 243 ASN45.56-Allowed (1.18%)
General case / -68.8,5.1
35.8% (p-10)
chi angles: 74.5,352.8
0.152Å--
A 244 VAL38.370.401Å
HG11 with A 188 ARG HG2
Favored (56.86%)
Isoleucine or valine / -60.3,-34.3
8.6% (p)
chi angles: 73.3
0.079Å--
A 245 ASP39.19-Favored (61.16%)
General case / -72.5,-24.5
76.7% (m-20)
chi angles: 288.8,146.7
0.106Å--
A 246 ILE36.570.52Å
HD11 with A 350 VAL HA
Favored (75.94%)
Isoleucine or valine / -65.6,-35.7
11.3% (mm)
chi angles: 284.9,287.8
0.128Å--
A 247 TRP33.7-Favored (96.5%)
General case / -60.6,-44.2
38.6% (t-105)
chi angles: 174.2,272.4
0.032Å--
A 248 SER35.84-Favored (93.36%)
General case / -64.1,-39.1
45.4% (m)
chi angles: 302.4
0.019Å--
A 249 VAL33.58-Favored (90.73%)
Isoleucine or valine / -64.2,-40.9
91.7% (t)
chi angles: 175.5
0.111Å--
A 250 GLY31.94-Favored (92.01%)
Glycine / -58.4,-47.0
----
A 251 CYS33.02-Favored (94.9%)
General case / -60.0,-44.1
90.3% (m)
chi angles: 293.3
0.024Å--
A 252 ILE34.67-Favored (78.18%)
Isoleucine or valine / -65.3,-49.6
71.3% (mt)
chi angles: 290.3,163.5
0.136Å--
A 253 MET39.35-Favored (87.36%)
General case / -59.5,-47.0
23.6% (ttt)
chi angles: 176.8,178.3,188.2
0.037Å--
A 254 GLY39.96-Favored (94.2%)
Glycine / -57.9,-41.6
----
A 255 GLU53.99-Favored (73.16%)
General case / -69.9,-34.1
61% (tt0)
chi angles: 189.6,170.1,155.4
0.024Å--
A 256 MET55.24-Favored (76.47%)
General case / -64.0,-33.8
9.1% (mtp)
chi angles: 272.9,158.2,98.8
0.018Å--
A 257 VAL47.19-Favored (15.83%)
Isoleucine or valine / -80.9,-51.3
75.5% (t)
chi angles: 172.9
0.115Å--
A 258 ARG64.08-Favored (59.1%)
General case / -75.0,-26.0
53.7% (mtt180)
chi angles: 286.6,204,187.2,156.6
0.054Å--
A 259 HIS50.41-Favored (10.19%)
General case / 67.1,21.3
84% (m-70)
chi angles: 308.1,285.6
0.178Å--
A 260 LYS107.96-Favored (31.34%)
General case / -144.1,143.9
39.1% (mtmt)
chi angles: 279.4,188.2,269.1,182.2
0.059Å--
A 261 ILE48.57-Favored (18.12%)
Isoleucine or valine / -55.7,130.4
61% (mt)
chi angles: 297.8,160.1
0.043Å--
A 262 LEU44.64-Favored (60.19%)
General case / -66.5,-51.1
17.8% (mt)
chi angles: 292.1,193.8
0.062Å--
A 263 PHE48.2-Favored (58.7%)
Pre-proline / -124.2,80.7
11.4% (m-85)
chi angles: 319.5,111.3
0.115Å--
A 264 PRO59.69-Favored (2.72%)
Trans proline / -83.7,79.6
65.7% (Cg_endo)
chi angles: 27.8,338.7,126.3
0.072Å--
A 265 GLY62.47-Favored (13.03%)
Glycine / -95.3,136.7
----
A 266 ARG113.29-Favored (59.7%)
General case / -75.0,-20.2
20.9% (ptt180)
chi angles: 45.4,166.4,168.7,170.8
0.073Å--
A 267 ASP79.32-Favored (17.65%)
General case / -155.9,172.9
1.7% (p30)
chi angles: 51.5,75.6
0.03Å--
A 268 TYR70.15-Favored (77.46%)
General case / -59.7,-36.9
2.6% (m-85)
chi angles: 274.7,143.4
0.092Å--
A 269 ILE62.91-Favored (16.34%)
Isoleucine or valine / -62.0,-56.6
24.7% (mm)
chi angles: 298.9,288.8
0.05Å--
A 270 ASP69.91-Favored (84.66%)
General case / -57.6,-43.7
22.9% (t0)
chi angles: 194.6,39.5
0.026Å--
A 271 GLN81.29-Favored (60.33%)
General case / -54.3,-52.8
49.5% (tp60)
chi angles: 187.7,81.2,51.2
0.059Å--
A 272 TRP49.6-Favored (85.16%)
General case / -59.9,-39.4
75.2% (t-105)
chi angles: 183.1,248.9
0.112Å--
A 273 ASN57.85-Favored (94.65%)
General case / -63.4,-44.4
92.4% (m-20)
chi angles: 293.3,325.8
0.063Å--
A 274 LYS90.28-Favored (78.61%)
General case / -63.7,-34.8
35.7% (mmtm)
chi angles: 302.4,277.4,197.5,290.7
0.042Å--
A 275 VAL44.73-Favored (18.9%)
Isoleucine or valine / -66.2,-55.4
40.9% (t)
chi angles: 166.7
0.082Å--
A 276 ILE54.83-Favored (76.09%)
Isoleucine or valine / -65.5,-35.8
16.4% (pt)
chi angles: 63.9,158.2
0.229Å--
A 277 GLU81.91-Favored (71.49%)
General case / -59.1,-34.0
23.5% (mt-10)
chi angles: 275.4,155.6,27.8
0.071Å--
A 278 GLN63.11-Favored (5.55%)
General case / -96.3,-48.6
74.1% (mt-30)
chi angles: 291.5,180.3,61.1
0.072Å--
A 279 LEU46.99-Favored (22.63%)
General case / -92.0,-19.2
41.4% (mt)
chi angles: 310,176.5
0.062Å--
A 280 GLY47.32-Favored (36.35%)
Glycine / 94.8,167.4
----
A 281 THR51.6-Favored (92.68%)
Pre-proline / -63.8,128.3
30.8% (m)
chi angles: 307.1
0.102Å--
A 282 PRO54.65-Favored (27.98%)
Trans proline / -68.0,165.5
51.7% (Cg_endo)
chi angles: 25.2,327.7,145.9
0.036Å--
A 283 CYS59.62-Favored (10.78%)
Pre-proline / -57.6,158.8
22.5% (p)
chi angles: 68.4
0.059Å--
A 284 PRO63.43-Favored (52.27%)
Trans proline / -65.7,-27.9
17.3% (Cg_exo)
chi angles: 345.6,29.7,87.3
0.032Å--
A 285 GLU58.86-Favored (74.15%)
General case / -61.3,-33.8
-0.029Å--
A 286 PHE56.67-Favored (74.29%)
General case / -69.1,-43.5
85.3% (t80)
chi angles: 174.7,80.8
0.024Å--
A 287 MET66.79-Favored (77.8%)
General case / -57.5,-40.0
14.1% (mmt)
chi angles: 308.7,300.2,194.6
0.025Å--
A 288 LYS124.48-Favored (62%)
General case / -57.8,-26.6
60.9% (mttm)
chi angles: 286.1,185.8,187.2,283.1
0.057Å--
A 289 LYS86.99-Favored (51.63%)
General case / -87.2,-10.8
47.5% (mtmt)
chi angles: 298.4,188.7,277.2,174.3
0.088Å--
A 290 LEU65.67-Favored (30.56%)
General case / -80.2,149.2
33% (mt)
chi angles: 289.9,159.5
0.021Å--
A 291 GLN115.51-Favored (96.98%)
Pre-proline / -62.6,140.7
0.1%
chi angles: 212,241.1,274.1
0.062Å--
A 292 PRO69.81-Favored (8.75%)
Trans proline / -42.7,-43.9
79.7% (Cg_exo)
chi angles: 330.5,31.1,100.4
0.061Å--
A 293 THR76.1-Favored (68.14%)
General case / -67.5,-48.1
69% (p)
chi angles: 63.2
0.143Å--
A 294 VAL65.26-Favored (98.24%)
Isoleucine or valine / -63.6,-43.5
10.8% (t)
chi angles: 192.3
0.165Å--
A 295 ARG114.86-Favored (77.33%)
General case / -55.6,-46.7
66.6% (ttt180)
chi angles: 189,181.2,184.5,165.7
0.065Å--
A 296 ASN99.67-Favored (96.43%)
General case / -61.0,-45.0
25.5% (t-20)
chi angles: 180.4,274.3
0.036Å--
A 297 TYR77.52-Favored (91.23%)
General case / -64.5,-44.4
80.6% (t80)
chi angles: 172.5,76.3
0.073Å--
A 298 VAL67.11-Favored (80.47%)
Isoleucine or valine / -69.4,-43.9
71.8% (t)
chi angles: 171.9
0.183Å--
A 299 GLU106.89-Favored (63.73%)
General case / -69.3,-22.7
53.3% (mt-10)
chi angles: 272.8,182,179.8
0.072Å--
A 300 ASN96.08-Favored (47.15%)
General case / -98.7,6.1
9.6% (m120)
chi angles: 278.2,92.8
0.12Å--
A 301 ARG115.630.421Å
HA with A 301 ARG HD2
Favored (79.99%)
Pre-proline / -77.8,156.6
0%
chi angles: 236.8,32.9,189.7,95.9
0.048Å--
A 302 PRO72.25-Favored (20.3%)
Trans proline / -62.0,127.1
20.8% (Cg_exo)
chi angles: 344.6,29.7,88.4
0.04Å--
A 303 LYS110.14-Favored (47.81%)
General case / -69.5,149.8
9% (mptt)
chi angles: 281.5,91.5,188.7,175.3
0.107Å--
A 304 TYR78.38-Favored (24.12%)
General case / -142.2,131.9
55.3% (m-85)
chi angles: 284,101.1
0.022Å--
A 305 ALA57.32-Favored (66.39%)
General case / -70.3,-29.6
-0.041Å--
A 306 GLY57.43-Favored (36.92%)
Glycine / 86.1,162.6
----
A 307 LEU60.67-Favored (23.79%)
General case / -97.3,147.8
5.5% (mp)
chi angles: 275.1,44.2
0.055Å--
A 308 THR54.89-Favored (35.79%)
General case / -75.2,156.5
27.1% (p)
chi angles: 71.3
0.03Å--
A 309 PHE53.65-Favored (31.12%)
Pre-proline / -63.7,-37.7
29% (m-85)
chi angles: 276.2,84
0.21Å--
A 310 PRO57.71-Favored (97.04%)
Trans proline / -59.5,-33.8
49.2% (Cg_exo)
chi angles: 337,35.7,86.1
0.024Å--
A 311 LYS107.8-Favored (62.58%)
General case / -73.2,-42.5
22.7% (mttp)
chi angles: 258.8,174.6,167.4,69.2
0.039Å--
A 312 LEU62.72-Favored (91.48%)
General case / -62.7,-45.7
33.5% (mt)
chi angles: 286.4,160.1
0.021Å--
A 313 PHE52.75-Favored (43.1%)
Pre-proline / -122.3,75.9
75.2% (m-85)
chi angles: 304.8,99.7
0.057Å--
A 314 PRO58.02-Favored (20.97%)
Trans proline / -61.1,162.0
33.2% (Cg_exo)
chi angles: 339.7,34.4,85.4
0.067Å--
A 315 ASP81.63-Favored (44.91%)
General case / -51.7,-35.9
76.2% (m-20)
chi angles: 298.7,156.1
0.026Å--
A 316 SER72.77-Favored (34.49%)
General case / -49.1,-41.2
1.6% (m)
chi angles: 321
0.037Å--
A 317 LEU63.25-Favored (62.95%)
General case / -70.5,-18.3
91.6% (mt)
chi angles: 299.7,178.2
0.077Å--
A 318 PHE69.150.436Å
C with A 320 ALA H
Favored (40.38%)
Pre-proline / -112.5,97.5
94.9% (m-85)
chi angles: 299,93.8
0.031Å--
A 319 PRO75.45-Allowed (0.17%)
Trans proline / -69.8,24.7
12.4% (Cg_exo)
chi angles: 348.7,30.2,83.4
0.081Å--
A 320 ALA72.190.436Å
H with A 318 PHE C
OUTLIER (0%)
General case / -35.2,85.2
-0.055Å--
A 321 ASP89.21-Allowed (1.08%)
General case / -82.7,-64.9
2.6% (p-10)
chi angles: 43.6,123.7
0.105Å--
A 322 SER57.89-Favored (13.63%)
General case / -74.5,171.5
53.7% (p)
chi angles: 74.2
0.016Å--
A 323 GLU57.14-Favored (79.79%)
General case / -68.8,-38.3
62% (mm-40)
chi angles: 287.9,290.3,172.2
0.041Å--
A 324 HIS53.17-Favored (64.15%)
General case / -54.1,-51.4
57.2% (t60)
chi angles: 169.8,89
0.023Å--
A 325 ASN58.73-Favored (83.56%)
General case / -65.4,-36.3
87.7% (m-20)
chi angles: 282.5,344.5
0.108Å--
A 326 LYS57.87-Favored (93.29%)
General case / -63.2,-45.1
77.1% (mttt)
chi angles: 280.4,181.1,169.4,162.3
0.023Å--
A 327 LEU41.43-Favored (76.24%)
General case / -67.9,-44.7
46.2% (tp)
chi angles: 181.6,56.6
0.036Å--
A 328 LYS75.17-Favored (77.92%)
General case / -62.8,-34.7
16.5% (mmtt)
chi angles: 290.2,279.5,140.9,202.4
0.068Å--
A 329 ALA41.13-Favored (91.36%)
General case / -65.6,-42.6
-0.035Å--
A 330 SER51.44-Favored (99.42%)
General case / -62.3,-42.5
9.7% (t)
chi angles: 163.9
0.025Å--
A 331 GLN48.45-Favored (75.44%)
General case / -69.9,-36.5
97.2% (mt-30)
chi angles: 293.5,174.7,340.2
0.046Å--
A 332 ALA39.86-Favored (82.81%)
General case / -63.9,-46.9
-0.057Å--
A 333 ARG91.12-Favored (86.72%)
General case / -65.6,-37.5
20.8% (ttm105)
chi angles: 195.2,198.2,279.9,106.7
0.116Å--
A 334 ASP43-Favored (99.5%)
General case / -62.4,-43.1
37.7% (t70)
chi angles: 183.4,66.4
0.04Å--
A 335 LEU38.82-Favored (86.85%)
General case / -67.1,-40.6
66.2% (tp)
chi angles: 179,62.8
0.108Å--
A 336 LEU42.76-Favored (85.37%)
General case / -57.7,-45.7
9% (mt)
chi angles: 267,168
0.054Å--
A 337 SER38.35-Favored (65.03%)
General case / -58.7,-27.7
17% (p)
chi angles: 81.3
0.086Å--
A 338 LYS49.95-Favored (19.88%)
General case / -90.6,-25.9
57.7% (mttm)
chi angles: 292.9,177,189.2,312.8
0.052Å--
A 339 MET40.02-Favored (14.91%)
General case / -87.8,-39.4
69% (mtm)
chi angles: 299.6,195.1,294.3
0.051Å--
A 340 LEU38.52-Favored (6.08%)
General case / -87.9,60.9
71.4% (mt)
chi angles: 286.9,168.9
0.05Å--
A 341 VAL40.36-Favored (64.29%)
Isoleucine or valine / -115.9,120.3
86.9% (t)
chi angles: 177.3
0.072Å--
A 342 ILE43.28-Favored (84.33%)
Isoleucine or valine / -58.2,-48.6
64.3% (mt)
chi angles: 296.3,160.5
0.138Å--
A 343 ASP58.11-Favored (37.39%)
Pre-proline / -75.3,114.6
55.3% (t0)
chi angles: 190.8,176.4
0.062Å--
A 344 PRO43.91-Favored (72.68%)
Trans proline / -63.2,-23.1
19% (Cg_endo)
chi angles: 17.9,332.7,145.6
0.071Å--
A 345 ALA47.48-Favored (65.75%)
General case / -67.2,-23.6
-0.033Å--
A 346 LYS87.52-Favored (16.72%)
General case / -111.1,-0.1
25.4% (mtmm)
chi angles: 289.6,186.7,268.4,288.3
0.032Å--
A 347 ARG44.36-Favored (29.31%)
General case / -87.4,140.7
34.8% (ttm180)
chi angles: 191.6,186,303.8,148.6
0.072Å--
A 348 ILE52.23-Favored (7.27%)
Isoleucine or valine / -58.8,147.7
12% (tt)
chi angles: 199.9,174.9
0.141Å--
A 349 SER44.25-Favored (10.42%)
General case / -87.1,171.8
89.9% (p)
chi angles: 65.7
0.076Å--
A 350 VAL40.420.52Å
HA with A 246 ILE HD11
Favored (98.04%)
Isoleucine or valine / -63.9,-44.5
53% (t)
chi angles: 170.5
0.137Å--
A 351 ASP59.57-Favored (97.41%)
General case / -61.5,-41.5
92.3% (m-20)
chi angles: 284.6,165.6
0.059Å--
A 352 ASP47.41-Favored (67.46%)
General case / -72.8,-35.6
87.1% (m-20)
chi angles: 294.9,156.7
0.13Å--
A 353 ALA40.48-Favored (82.59%)
General case / -62.7,-36.4
-0.015Å--
A 354 LEU42.81-Favored (61.75%)
General case / -71.5,-22.9
18.8% (mt)
chi angles: 283,157.4
0.019Å--
A 355 GLN90.8-Favored (47.43%)
General case / -91.8,-8.2
14.3% (mm100)
chi angles: 288.8,276.4,68
0.036Å--
A 356 HIS42.77-Favored (95.66%)
Pre-proline / -66.3,137.9
65.3% (t-80)
chi angles: 190,280.2
0.038Å--
A 357 PRO45.4-Favored (66%)
Trans proline / -52.0,-36.6
53% (Cg_exo)
chi angles: 334.8,34.2,91
0.051Å--
A 358 TYR41.97-Favored (73.6%)
General case / -59.7,-35.0
33.5% (t80)
chi angles: 194.5,69.3
0.058Å--
A 359 ILE46.22-Favored (12.31%)
Isoleucine or valine / -96.7,-42.9
45.1% (mm)
chi angles: 304,304.2
0.091Å--
A 360 ASN85.76-Allowed (0.23%)
General case / -42.5,-28.7
5.4% (t-20)
chi angles: 217.4,7.2
0.034Å--
A 361 VAL48.36-Favored (27.41%)
Isoleucine or valine / -63.3,-21.1
11.8% (m)
chi angles: 307.4
0.175Å--
A 362 TRP48.8-Favored (19.5%)
General case / -98.9,-14.7
82.3% (m95)
chi angles: 302.7,109.7
0.022Å--
A 363 TYR55.26-Allowed (0.85%)
General case / -41.8,116.8
12.1% (t80)
chi angles: 200.6,100
0.127Å--
A 364 ASP64.85-Favored (13.69%)
Pre-proline / -134.2,117.9
65.1% (t0)
chi angles: 180.4,176.3
0.048Å--
A 365 PRO66.98-Favored (82.7%)
Trans proline / -57.4,-29.0
48.8% (Cg_exo)
chi angles: 337,36.4,85
0.057Å--
A 366 ALA63.81-Favored (67.16%)
General case / -67.7,-27.9
-0.023Å--
A 367 GLU73.71-Favored (11.37%)
General case / -92.2,-39.8
69.8% (mt-10)
chi angles: 303.4,168.1,150.3
0.016Å--
A 368 VAL64.48-Favored (16.38%)
Isoleucine or valine / -82.1,-39.3
98.5% (t)
chi angles: 178.4
0.102Å--
A 369 GLU102.73-Favored (4.02%)
General case / -110.7,34.4
14.8% (mt-10)
chi angles: 297.7,151.8,61
0.068Å--
A 370 ALA79.04-Favored (85.78%)
Pre-proline / -60.5,146.2
-0.029Å--
A 371 PRO85.31-Favored (35%)
Trans proline / -57.0,129.5
49.5% (Cg_exo)
chi angles: 336.9,35.6,86.4
0.054Å--
A 372 PRO91.77-Favored (3.94%)
Trans proline / -78.6,117.2
2.1% (Cg_endo)
chi angles: 1.3,17.4,91.3
0.021Å--
A 373 PRO96.170.434Å
HG2 with A 118 VAL HA
Favored (14.96%)
Trans proline / -80.5,142.9
4.9% (Cg_exo)
chi angles: 358.6,22.6,85.5
0.053Å--
A 374 GLN135.93---0.038Å--
A 379 GLN108.68---0.05Å--
A 380 LEU111.39-Favored (6.94%)
General case / -130.9,104.1
2.6% (mp)
chi angles: 308.2,101.5
0.03Å--
A 381 ASP115.08-Favored (22.5%)
General case / -164.2,161.9
21.8% (t0)
chi angles: 198.8,33.4
0.036Å--
A 382 GLU97.86-OUTLIER (0.03%)
General case / 52.0,87.9
-0.102Å--
A 383 ARG92.19-Favored (3.48%)
General case / -164.3,132.5
-0.031Å--
A 384 GLU110.87-Favored (37.72%)
General case / -78.4,136.8
5.4% (pt-20)
chi angles: 61.5,159.6,96
0.081Å--
A 385 HIS76.65-Favored (44.91%)
General case / -141.9,154.2
92.6% (m-70)
chi angles: 290.6,288.9
0.051Å--
A 386 THR69.81-Favored (13.46%)
General case / -81.4,172.5
41.3% (p)
chi angles: 54.3
0.049Å--
A 387 ILE60.31-Favored (61.49%)
Isoleucine or valine / -55.3,-50.9
86.4% (mt)
chi angles: 294.9,165.4
0.06Å--
A 388 GLU83.4-Favored (84.79%)
General case / -57.5,-45.5
0%
chi angles: 23.5,151.1,68.8
0.105Å--
A 389 GLU76.54-Favored (81.58%)
General case / -66.8,-44.3
75.9% (mt-10)
chi angles: 293.1,159.6,161.2
0.027Å--
A 390 TRP45.72-Favored (96.31%)
General case / -61.4,-40.9
5.7% (m95)
chi angles: 278.1,132.3
0.023Å--
A 391 LYS74.79-Favored (83.33%)
General case / -57.5,-46.8
80% (tttt)
chi angles: 189.2,174.7,185.7,191.3
0.029Å--
A 392 GLU84.26-Favored (73.02%)
General case / -70.9,-37.9
20.6% (tt0)
chi angles: 203.3,174.9,90.5
0.093Å--
A 393 LEU54.63-Favored (91.37%)
General case / -65.6,-42.8
27.1% (mt)
chi angles: 287.1,158.4
0.074Å--
A 394 ILE52.56-Favored (80.19%)
Isoleucine or valine / -68.5,-46.5
62.8% (mt)
chi angles: 293,159.7
0.153Å--
A 395 TYR63.24-Favored (86.9%)
General case / -58.0,-44.0
73.5% (t80)
chi angles: 184.4,71
0.037Å--
A 396 LYS111.46-Favored (95.07%)
General case / -63.6,-39.7
84.9% (mttt)
chi angles: 278.9,168.9,181.4,174.5
0.057Å--
A 397 GLU80.57-Favored (94.69%)
General case / -65.2,-40.6
6% (tp10)
chi angles: 207.3,47.3,61.2
0.049Å--
A 398 VAL59.96-Favored (83.88%)
Isoleucine or valine / -67.6,-46.0
53.9% (t)
chi angles: 170.2
0.124Å--
A 399 MET70.65-Favored (61.71%)
General case / -73.9,-28.7
34.1% (mmt)
chi angles: 295.3,291.5,93.5
0.088Å--
A 400 ASN125.92--1.3% (m-20)
chi angles: 241.3,334.8
0.116Å--
A 502 ANP53.38------
A 501 88044.2------
A 601 HOH36.65------
A 602 HOH30.07------
A 603 HOH40.95------
A 604 HOH38.19------
A 605 HOH40.11------
A 606 HOH35.6------
A 607 HOH38.83------
A 608 HOH37.61------
A 609 HOH37.51------
A 610 HOH40.26------
A 611 HOH45.84------
A 612 HOH39.69------
A 613 HOH34.95------
A 614 HOH41.92------
A 615 HOH37.23------
A 616 HOH41.17------
A 617 HOH47.49------
A 619 HOH45.33------
A 621 HOH48.86------
A 622 HOH46.85------
A 623 HOH51.26------
A 624 HOH54.01------
A 625 HOH35.11------
A 626 HOH41.62------
A 627 HOH38.82------
A 628 HOH49.99------
A 629 HOH44.92------
A 631 HOH41.05------
A 632 HOH41.84------
A 633 HOH50.41------
A 634 HOH48.77------
A 639 HOH38.2------
A 640 HOH45.96------
A 641 HOH45.04------
A 642 HOH49.07------
A 646 HOH51.83------
A 647 HOH43.59------
A 648 HOH50.28------
A 649 HOH54.05------
A 651 HOH47.17------
A 654 HOH44.7------
A 655 HOH47.05------
A 656 HOH48.07------
A 658 HOH43.4------
A 659 HOH66.15------
A 663 HOH56.09------
A 664 HOH60.54------
A 665 HOH50.94------
A 669 HOH63.28------
A 671 HOH46.4------
A 677 HOH49.11------
A 680 HOH43.9------
A 681 HOH51.07------
A 682 HOH66.91------